Green Cross Holdings Corporation (KRX:005250)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,160
+1,240 (8.31%)
Last updated: Jun 5, 2025
14.20%
Market Cap 733.69B
Revenue (ttm) 2.23T
Net Income (ttm) 67.23B
Shares Out 45.40M
EPS (ttm) 1,477.28
PE Ratio 10.94
Forward PE n/a
Dividend 500.00 (3.09%)
Ex-Dividend Date Dec 27, 2024
Volume 412,137
Average Volume 84,333
Open 15,320
Previous Close 14,920
Day's Range 15,170 - 16,290
52-Week Range 12,000 - 18,490
Beta 1.11
RSI 78.96
Earnings Date May 15, 2025

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1967
Employees 151
Stock Exchange Korea Stock Exchange
Ticker Symbol 005250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.